Drug Screen — 10-Panel Urine

A ten-substance urine drug screen covering amphetamine, barbiturates, benzodiazepines, cocaine, ecstasy (MDMA), methamphetamine, opiates, methadone, tricyclic antidepressants, and marijuana (THC). Performed by immunoassay at PKBH Olomouc on a single spot urine sample — no blood draw required. At 454 Kč with same-day results, this is among the most affordable validated drug panels in the Czech Republic. Walk-in, no referral.

A ten-panel urine drug screen is the standard assay for workplace drug testing, pre-employment screening, probation compliance, custody disputes, and personal health monitoring. PKBH's panel covers the ten substance classes most commonly screened in Czech occupational health and clinical settings. **Substances screened (immunoassay method):** 1. **Amphetamine** — covers amphetamine and substituted amphetamine derivatives used recreationally. 2. **Barbiturates** — sedative-hypnotic drugs (phenobarbital, secobarbital). Positive results require prescription documentation. 3. **Benzodiazepines** — tranquillisers and sleep medications (diazepam, lorazepam, clonazepam). Screens detect most common BZDs; some newer or atypical benzodiazepines may not be detected. 4. **Cocaine (benzoylecgonine)** — detects the primary cocaine metabolite, present in urine for 2–4 days after use (up to 14 days in heavy users). 5. **Ecstasy (MDMA / 3,4-methylenedioxymethamphetamine)** — the active component in recreational "ecstasy" tablets. 6. **Methamphetamine** — covers methamphetamine and related stimulants. Note: ephedrine-containing cold medications can produce cross-reactive positive results. 7. **Opiates** — screens for morphine, codeine, and heroin metabolites. High-dose codeine medications and poppy-seed ingestion can cause positive results. 8. **Methadone** — detected separately from general opiates; relevant for opioid replacement therapy monitoring. 9. **Tricyclic antidepressants (TCAs)** — includes amitriptyline, imipramine, doxepin. Relevant in psychiatric medication monitoring and overdose investigation. 10. **Marijuana (THC/cannabinoids)** — detects delta-9-THC metabolites. Detection window is 3–4 days for occasional users; up to 30 days in daily users. **Method:** Immunoassay-based lateral flow or enzyme-linked immunosorbent assay (ELISA) on spot urine. Positive immunoassay results can be confirmed by GC-MS (gas chromatography–mass spectrometry) at a reference laboratory — ask PKBH about reflex confirmation testing if medicolegal documentation is required. **Detection windows (general guidance):** Amphetamines 2–3 days; cocaine 2–4 days; opiates 2–3 days; marijuana 3–30 days (use-frequency dependent); benzodiazepines 1–7 days (drug dependent); barbiturates 2–4 days. **Who benefits:** Employers conducting occupational health drug screening; individuals subject to probation or legal monitoring; parents concerned about adolescent substance use; athletes in non-WADA settings monitoring for prohibited substances; anyone seeking personal confirmation of a drug-free status. **Preparation:** Provide a spot (mid-stream) urine sample at the PKBH collection site. No fasting required. No blood draw. Walk in from 07:00 — no appointment or referral needed.